| 1a | Re-elect William G. Kaelin Jr. - Non-Executive Director | Oppose |
| 1b | Re-elect David A. Ricks - Chair & Chief Executive | Oppose |
| 1c | Re-elect Marschall S. Runge - Non-Executive Director | Oppose |
| 1d | Re-elect Karen Walker - Non-Executive Director | For |
| 2 | Advisory Vote on Executive Compensation | Oppose |
| 3 | Approve the Frequency of Future Advisory Votes on Executive Compensation | 1 |
| 4 | Appoint the Auditors | Oppose |
| 5 | Board Proposal to Declassify the Board | For |
| 6 | Amend the Company's Articles of Incorporation to Eliminate Supermajority Voting Provisions | For |
| 7 | Shareholder Resolution: Publish an Annual Report Disclosing Lobbying Activities | For |
| 8 | Shareholder Resolution: Simple Majority Voting | For |
| 9 | Shareholder Resolution: Report on a Process by which the Impact of Extended Patent Exclusivities on Product Access Would be Considered in Deciding Whether to Apply for Secondary and Tertiary Patents | For |
| 10 | Shareholder Resolution: Report on Risks of Supporting Abortion | Oppose |
| 11 | Shareholder Resolution: Disclose Lobbying Activities and Alignment with Public Policy Positions and Statements | For |
| 12 | Shareholder Resolution: Report on Effectiveness of the Company's Diversity, Equity, and Inclusion Efforts | For |
| 13 | Shareholder Resolution: Adopt a Policy to Require Certain Third-Party Organizations to Annually Report Expenditures for Political Activities before Lilly Contributes to an Organization | For |
